Analgesic Efficacy and Safety of Topical VMD-3866 Gel in Management of Pain Induced by Chemotherapy (CIPN)

Clinical trial NCT07072468 · RECRUITING

Trial details

NCT number: NCT07072468
Sponsor: VM Therapeutics LLC
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chemotherapy-induced Peripheral Neuropathy Drug-Induced Nephropathy

Start date: 2025-12-12
Primary completion: 2027-06-30
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.